EDSA
Edesa Biotech, Inc.
NasdaqCMUSDEQUITY
DELAYED
Last price
4.43
▼ 0.33 (6.93%)
MARKET · —
Price
Open
4.86
Prev close
4.76
Day high
4.95
Day low
4.22
Volume
156.13K
Market cap
—
P/E (TTM)
—
52W range
0.72 – 20.32
Trailing performance
Returnvs SPY
1W
-17.20%
-15.8%
1M
-21.73%
-25.5%
3M
-59.25%
-62.3%
6M
+453.75%
+442.7%
YTD
+211.97%
+199.7%
1Y
+87.71%
+67.7%
3Y
-24.66%
-98.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
5.31
-16.64% from price
SMA 20
5.26
-15.83% from price
SMA 50
6.21
-28.62% from price
SMA 100
7.83
-43.41% from price
SMA 200
5.13
-13.69% from price
EMA 12
5.25
-15.57% from price
EMA 26
5.58
-20.59% from price
EMA 50
6.17
-28.25% from price
RSI (14)
33.0
Neutral
MACD (12,26,9)
-0.33
Hist 0.02
ATR (14)
0.65
14.75% of price
Realised vol 30D
86.0%
Annualised
Bollinger upper
5.87
20, 2σ
Bollinger lower
4.66
20, 2σ
50 / 200 cross
Golden
6.21 vs 5.13
Trend bias
Below 200
-13.69%
Risk profile
Beta vs SPY
-0.63
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
86.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-75.8%
Peak to trough
Max drawdown 5Y
-99.0%
Peak to trough
ATR 14
0.65
14.75% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Edesa Biotech Stock Sinks After Fresh Capital Raise
Benzinga · 2d ago
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
GlobeNewswire · 3d ago
Edesa Biotech Launches Public Offering of Common Shares, Warrants
MT Newswires · 3d ago
Edesa Biotech Announces Proposed Public Offering
GlobeNewswire · 3d ago
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
GlobeNewswire · 9d ago
EDSA: Positive Exploratory Data in Patients with AKI
Zacks Small Cap Research · 51d ago
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors
GlobeNewswire · 72d ago
Sector Update: Healthcare Stocks Gain Friday Afternoon
MT Newswires · 78d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.